Qin Shi

Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China

Anwen Xiong, Lei Wang, Jianhua Chen et al. · The Lancet · 2025 · 133 citations

Medicine, Oncology, Pharmacology +13

MiR-181a inhibits non-small cell lung cancer cell proliferation by targeting CDK1

Qin Shi, Zhan Zhou, Naishu Ye et al. · Cancer Biomarkers · 2017 · 79 citations

Medicine, Molecular Biology, Oncology +17

Differentiation of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells into endometrial cells

Qin Shi, Jingwei Gao, Yao Jiang et al. · Stem Cell Research & Therapy · 2017 · 69 citations · Full text

Life Sciences, Biotechnology, Cell Biology +14

Early diagnosis of bacterial infection in patients with septicopyemia by laboratory analysis of PCT, CRP and IL-6

Liqin Gao, Xinghui Liu, Denghai Zhang et al. · Experimental and Therapeutic Medicine · 2017 · 68 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +15

Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first‐line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open‐label, parallel controlled clinical study

Jie Zhang, Yueyin Pan, Qin Shi et al. · Cancer Communications · 2021 · 65 citations · Full text

Medicine, Oncology, Pharmacology +17